1. Home
  2. LVTX

as 07-22-2024 1:33pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

Founded: 2016 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 47.3M IPO Year: 2021
Target Price: $6.00 AVG Volume (30 days): 89.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.15 EPS Growth: N/A
52 Week Low/High: $1.13 - $6.47 Next Earning Date: 08-20-2024
Revenue: $13,627,174 Revenue Growth: -36.01%
Revenue Growth (this year): 5.36% Revenue Growth (next year): N/A

LVTX Daily Stock ML Predictions

Share on Social Networks: